Patent 7268245 was granted and assigned to Sonus Pharmaceuticals Inc. on September, 2007 by the United States Patent and Trademark Office.
Multinuclear platinum compounds, compositions that include the platinum compounds, methods for making the platinum compounds, and methods for treating cellular proliferative diseases by administering the platinum compounds.